This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Progressive's (PGR) Premium Growth Impresses, Cat Loss a Woe
by Zacks Equity Research
Progressive's (PGR) sustained operational performance, prudent acquisitions and robust capital position continue to impress. However, exposure to cat loss remains a headwind.
Reinsurance Group's Organic Growth Impresses, High Costs Ail
by Zacks Equity Research
Reinsurance Group (RGA) encourages with growth in operating income, improving net investment income and a solid financial position. However, rising expenses raise concerns.
RLI Corp.'s Premium Growth Impresses, Rising Costs a Woe
by Zacks Equity Research
RLI Corp.'s (RLI) sustained operational performance, prudent initiatives and a robust capital position continue to impress. However, rising expenses remain a headwind.
Why CNO Financial Group (CNO) Could Be a Top Value Stock Pick
by Zacks Equity Research
CNO Financial Group (CNO) seems to be a good value pick, as it has impressive value metrics, and is seeing solid earnings estimate revisions as well.
Here's Why You Should Retain Unum Group (UNM) Stock Now?
by Zacks Equity Research
Unum Group (UNM) impresses with operating income growth, solid performance at Unum U.S. and Colonial Life and a robust capital position. Higher expenses are a challenge.
Atlas Financial (AFH) & Units' Ratings Retained By A.M. Best
by Zacks Equity Research
Atlas Financial (AFH) and subsidiaries receive rating action from A.M. Best, which might help the property and casualty (P&C) insurer retain investors' faith and write more business in the future.
Nasdaq to Boost Market Surveillance With Sybenetix Buyout
by Zacks Equity Research
Nasdaq (NDAQ) expects to expand market technology business as well as boost market surveillance techniques with the purchase of Sybenetix, which in turn will fortify its service portfolio.
AmTrust (AFSI) to Sell Policy Management System for $200M
by Zacks Equity Research
AmTrust's (AFSI) decision to sell its policy management system to National General holds promise to improve the overall performance of the P&C insurer.
Prudential Financial's (PRU) Subordinated Notes Get Rated
by Zacks Equity Research
Ratings of Prudential Financial's (PRU) subordinated notes by credit rating agencies reflect its robust performance across all its segments.
Radian Group Raises Notes Offering to $450M, Gets Rated
by Zacks Equity Research
Radian Group (RDN) raises senior notes offering to fund tender offers as well buyback outstanding debts. The ratings by Moody's reflect the company's refined profitability standards.
MGIC Investment vs. Radian Group: Which Stock Fares Better?
by Zacks Equity Research
On comparative analysis, we try and find out which stock -- Radian Group (RDN) or MGIC Investment (MTG) -- is better positioned in terms of fundamentals.
Radian Group on Growth Ground: Time to Retain the Stock
by Zacks Equity Research
Radian Group's (RDN) robust mortgage insurance portfolio, declining claim payments and laudable growth initiatives make it a lucrative stock.
Cigna's (CI) Unsecured Debts Receive Ratings From Moody's
by Zacks Equity Research
Unsecured debt ratings of Cigna assigned by Moody's reflect the company's robust business profile and wide national presence.
Loews (L) Gears Up for Growth: Apt to Hold the Stock Now?
by Zacks Equity Research
Loews (L) offers optimism with a few growth-boosting initiatives and a positive earnings track record.
Radian Group???s (RDN) Unit???s New Solution to Boost Services
by Zacks Equity Research
Radian Group's (RDN) unit comes up with a new solution to ensure growth of private label issuance and improve the company's service portfolio.
Why Is CNO Financial (CNO) Up 2.7% Since the Last Earnings Report?
by Zacks Equity Research
CNO Financial (CNO) reported earnings about a month ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Retain Willis Towers (WLTW) Stock Now
by Zacks Equity Research
Willis Towers' (WLTW) improving commissions and fees, continued operating income growth and a solid capital position make it an investment-friendly stock. However, rising expenses are a challenge.
Why Should You Hold on to Arch Capital (ACGL) Stock Now?
by Zacks Equity Research
Arch Capital's (ACGL) continued premium growth, evolving U.S. Mortgage Insurance business and a firm capital position make it an investment-worthy stock. However, rising expenses raise concerns.
Forget MetLife (MET), Buy These 3 Insurance Stocks Instead
by Zacks Equity Research
MetLife's (MET) declining revenues from low premiums, fees and other revenues, macroeconomic factors, and low return on equity make it an unattractive stock now.
China Life's (LFC) 1H17 Earnings & Revenues Increase Y/Y
by Zacks Equity Research
China Life's (LFC) strong first-half 2017 earnings were primarily driven by higher premiums that added to the top line.
Hartford Financial's Growth Potential Hurt by Weak Segments
by Zacks Equity Research
Hartford Financial's strong capital position aids in effective capital deployment, which in turn boosts shareholders' confidence. However, weak personal lines in Talcott Resolution, hurt margin.
Why You Should Hold Onto Prudential Financial (PRU) Stock?
by Zacks Equity Research
Prudential Financial's (PRU) solid pension risk transfer (PRT) business, growing international operations and robust capital position continue to impress. However, rising expenses raise concerns.
Lincoln National (LNC) Launches i4LIFE to Benefit Retirees
by Zacks Equity Research
Lincoln National (LNC) recently launched a fixed-indexed annuity benefit rider named "i4Life Indexed Advantage" to provide dependable, tax efficient income for life.
Zacks Industry Outlook Highlights: Health Insurance Innovations, Kemper Corporation and CNO Financial Group
by Zacks Equity Research
Zacks Industry Outlook Highlights: Health Insurance Innovations, Kemper Corporation and CNO Financial Group
Here's Why You Should Retain Travelers (TRV) Stock Right Now
by Zacks Equity Research
Travelers' (TRV) impressive inorganic portfolio, solid premium growth and a robust capital position continue to boost overall results. However, exposure to catastrophe losses remains a challenge.